Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community Short-Video Intervention in Rural Beijing
KAP-SHORT
Development and Application of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community-Targeted Short-Video Intervention in Suburban Beijing
2 other identifiers
interventional
1,062
1 country
1
Brief Summary
This is a two-phase, non-randomized clinical trial conducted in eight communities in Miyun District, Beijing. The study first develops and validates a reliable 18-item questionnaire (Knowledge, Attitudes, and Practices \[KAP\] scale) to assess community residents' understanding, attitudes, and behaviors related to secondary hypertension. Then, we evaluate whether a 1-week community-centered short-video health education intervention (five 1-minute videos delivered via community WeChat groups by local physicians) can improve residents' secondary hypertension-related knowledge, attitudes, and practices. We will compare scores before and after the intervention, and analyze which groups (such as rural residents, people with lower education, older adults) benefit more. This study aims to provide a simple assessment tool and a scalable health education model for secondary hypertension in community settings, especially for rural and low-educated populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedMarch 27, 2026
March 1, 2026
2 months
March 9, 2026
March 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in total score of the Secondary Hypertension Knowledge, Attitudes, and Practices (KAP) scale
The total score of the validated 18-item KAP scale for secondary hypertension will be measured at baseline and post-intervention. The scale includes knowledge, attitudes, and practices dimensions using a 5-point Likert scale. A higher total score indicates better knowledge, more positive attitudes, and better practices related to secondary hypertension. The primary outcome is the mean change from baseline to post-intervention.
Baseline (1 day before intervention) and within 24 hours after the 1-week intervention
Study Arms (1)
Community-Based Short-Video Intervention Group
EXPERIMENTALParticipants received a one-week short-video intervention on secondary hypertension. Five one-minute videos covered definition, symptoms, screening, treatment, and prognosis. Videos were delivered via community WeChat groups. Community physicians monitored engagement. KAP scores were measured pre- and post-intervention.
Interventions
Participants received five one-minute educational videos about secondary hypertension via community WeChat groups over one week. Videos covered definition, symptoms, screening, treatment, and prognosis. Content was reviewed by specialists. Community physicians monitored engagement and sent reminders. The intervention aims to improve KAP levels.
Eligibility Criteria
You may qualify if:
- Permanent residents aged ≥18 years with basic comprehension abilities, capable of completing the online questionnaire independently or with assistance
- Voluntary participation and signed informed consent
- For Phase 2 (Intervention Phase) only:
- Individuals with confirmed hypertension or family members cohabiting with hypertensive patients
- Member of a community WeChat group with the ability to receive and view short videos, and to complete online questionnaires independently or with assistance
You may not qualify if:
- \- Cognitive impairment that would interfere with understanding the questionnaire or video content
- Prior participation in standardized secondary hypertension public education programs
- Inability to use WeChat or access short videos (for Phase 2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University First Hospital
Beijing, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 27, 2026
Study Start
December 1, 2025
Primary Completion
January 31, 2026
Study Completion
March 1, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share